Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 167, Issue -, Pages 148-169Publisher
ELSEVIER
DOI: 10.1016/j.addr.2020.06.029
Keywords
Animal models; Inhalation; Pharmacodynamics; Pharmacokinetics; Toxicokinetics
Categories
Funding
- French National Research Agency (ANR) as part of the Investissements d'Avenir program [ANR-10-LABX-53-01]
Ask authors/readers for more resources
Nonclinical studies are fundamental for the development of inhaled drugs, as for any drug product, and for successful translation to clinical practice. They include in silico, in vitro, ex vivo and in vivo studies and are intended to provide a comprehensive understanding of the inhaled drug beneficial and detrimental effects. To date, animal models cannot be circumvented during drug development programs, acting as surrogates of humans to predict inhaled drug response, fate and toxicity. Herein, we review the animal models used during the different development stages of inhaled pharmaceuticals and biopharmaceuticals, highlighting their strengths and limitations. (C) 2020 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available